Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2025-12-26 @ 4:16 AM
Study NCT ID:
NCT05776927
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-11-26
First Post:
2023-03-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-05-29
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-12-21
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-12-24
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-06
First Submit QC Date:
None
Study First Post Date:
2023-03-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-25
Last Update Post Date:
2025-11-26
Last Update Post Date Type:
ESTIMATED